Blueprint Medicines Corporation (BPMC) Covered Calls

Blueprint Medicines Corpis a biopharmaceutical company. It is focused on improving the lives of patients with genomically defined diseases driven by abnormal kinase activation.

You can sell covered calls on Blueprint Medicines Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for BPMC (prices last updated Fri 4:16 PM ET):

Blueprint Medicines Corporation (BPMC) Stock Quote
Last	Change	Bid	Ask	Volume	P/E	Market Cap
89.40	-2.22	87.25	92.08	638K	-	5.8

Covered Calls For Blueprint Medicines Corporation (BPMC)
Expiration	Strike	Call Bid	Net Debit	Return If Flat	Annualized Return If Flat
Jan 17	90	3.80	88.28	1.9%	31.5%
Feb 21	90	6.40	85.68	5.0%	32.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls? Sign Up For A Free Trial

Extended Business Description

Blueprint Medicines Corp. is a biopharmaceutical company, which engages in developing of kinase inhibitors for genomically defined subsets of cancer patients. It has developed a platform that combines genomics with a novel library of kinase inhibitors, enabling the development of potent highly selective compounds against clear genomic driver targets. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.

Top 10 Open Interest For Jan 17 Expiration				Top 5 High Yield
1.	NVDA covered calls	6.	XLF covered calls	1.	NMRA covered calls
2.	SLV covered calls	7.	SPY covered calls	2.	QBTS covered calls
3.	AAPL covered calls	8.	IWM covered calls	3.	QUBT covered calls
4.	EEM covered calls	9.	TSLA covered calls	4.	QS covered calls
5.	INTC covered calls	10.	TLT covered calls	5.	JSPR covered calls

Want more examples? BP Covered Calls | BPOP Covered Calls